These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33654598)

  • 21. Clinical Application of
    Shoura S; Malhotra S
    J Nucl Med Technol; 2023 Jun; 51(2):125-128. PubMed ID: 37268320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transthyretin cardiac amyloidosis: an under-diagnosed cause of heart failure.
    Molina O G; Judge D; Campbell W; Chahal H; Mugmon M
    J Community Hosp Intern Med Perspect; 2014; 4(5):25500. PubMed ID: 25432650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abrupt Onset of Refractory Heart Failure Associated With Light-Chain Amyloidosis in Hypertrophic Cardiomyopathy.
    Tomberli B; Cappelli F; Perfetto F; Olivotto I
    JAMA Cardiol; 2017 Jan; 2(1):94-97. PubMed ID: 27806176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac Amyloidosis Imaging, Part 3: Interpretation, Diagnosis, and Treatment.
    Jerome S; Farrell MB; Warren J; Embry-Dierson M; Schockling EJ
    J Nucl Med Technol; 2023 Jun; 51(2):102-116. PubMed ID: 37268322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ruptured Bullae: A Case of Transthyretin Cardiac Amyloidosis.
    Dayco J; Weaver M; Sumbal N; Theisen R; Raheem S
    Cureus; 2021 Jul; 13(7):e16318. PubMed ID: 34395106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Practical recommendations for the diagnosis and management of transthyretin cardiac amyloidosis.
    Bistola V; Parissis J; Foukarakis E; Valsamaki PN; Anastasakis A; Koutsis G; Efthimiadis G; Kastritis E
    Heart Fail Rev; 2021 Jul; 26(4):861-879. PubMed ID: 33452596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac Amyloidosis: A Rare Cause of Recurrent Chylothorax.
    Patel R; Shah Z; Santo I; Anwer F
    Cureus; 2022 May; 14(5):e24861. PubMed ID: 35702470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent advances in the diagnosis and management of cardiac amyloidosis.
    Sher T; Gertz MA
    Future Cardiol; 2014 Jan; 10(1):131-46. PubMed ID: 24344669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitral and tricuspid stenosis caused by light chain cardiac amyloid deposition.
    Randhawa VK; Vakamudi S; Phelan DM; Samaras CJ; McKenney JK; Hanna M; Perez AL
    ESC Heart Fail; 2020 Jun; 7(3):1130-1135. PubMed ID: 32175673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac amyloidosis: updates in diagnosis and management.
    Mohty D; Damy T; Cosnay P; Echahidi N; Casset-Senon D; Virot P; Jaccard A
    Arch Cardiovasc Dis; 2013 Oct; 106(10):528-40. PubMed ID: 24070600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent advances in the diagnosis and management of amyloid cardiomyopathy.
    Nijst P; Tang WW
    Fac Rev; 2021; 10():31. PubMed ID: 33817700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis and Treatment of Cardiac Amyloidosis Related to Plasma Cell Dyscrasias.
    Alexander KM; Evangelisti A; Witteles RM
    Cardiol Clin; 2019 Nov; 37(4):487-495. PubMed ID: 31587789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Marked recovery of cardiac function by chemotherapy and autologous stem cell transplantation of a patient with heart failure with preserved ejection fraction due to primary amyloid light-chain amyloidosis: a case report.
    Tanaka H; Kitao A; Minami H; Hirata KI
    Eur Heart J Case Rep; 2022 Mar; 6(3):ytac016. PubMed ID: 35291337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amyloid cardiomyopathy: a hidden heart failure cause that is often misdiagnosed.
    Tung-Chen Y; Arnau MÁ
    Acta Clin Belg; 2018 Dec; 73(6):460-461. PubMed ID: 29663861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infusion of light chains from patients with cardiac amyloidosis causes diastolic dysfunction in isolated mouse hearts.
    Liao R; Jain M; Teller P; Connors LH; Ngoy S; Skinner M; Falk RH; Apstein CS
    Circulation; 2001 Oct; 104(14):1594-7. PubMed ID: 11581134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new therapy for transthyretin amyloidosis, no longer an orphan condition.
    Quarta CC; Tinuper AL; Milandri A; Gagliardi C; Caponeti G; Rapezzi C
    Eur Heart J Suppl; 2020 Jun; 22(Suppl E):E125-E131. PubMed ID: 32523456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A challenging road to diagnosing transthyretin cardiac amyloidosis and using technetium-99m pyrophosphate bone scintigraphy in nuclear cardiology - A case report.
    Kavita A; Abdul Onny MA; Suppiah S; Abdul Aziz AF; Hashim H; Raja Shariff RE; Ng CS
    Med J Malaysia; 2021 Sep; 76(5):762-767. PubMed ID: 34508392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical evaluation of infiltrative cardiomyopathies resulting in heart failure with preserved ejection fraction.
    Madan N; Kalra D
    Rev Cardiovasc Med; 2020 Jun; 21(2):181-190. PubMed ID: 32706207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heart failure as the first manifestation of severe non-cardiac disease.
    Matuszna A; Meryn J; Bachorski W
    Pol Merkur Lekarski; 2019 Aug; 47(278):67-69. PubMed ID: 31473755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Noninvasive Diagnostic Modalities in an Isolated Case of Cardiac Amyloidosis.
    Lewars J; Wazir H; Gordon B; Faluyi U; Girgis Y
    Cureus; 2021 Apr; 13(4):e14608. PubMed ID: 34040908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.